BCD-131 (pegylated darbepoetin beta biosimilar)
/ Biocad
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 18, 2025
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
(clinicaltrials.gov)
- P3 | N=228 | Recruiting | Sponsor: Biocad
New P3 trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
July 16, 2018
Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
(clinicaltrials.gov)
- P2; N=100; Active, not recruiting; Sponsor: Biocad; Recruiting ➔ Active, not recruiting
Enrollment closed • Anemia • Biosimilar • Chronic Kidney Disease • Hematological Disorders • Renal Disease
1 to 2
Of
2
Go to page
1